RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID)
CUSIP: 75340L104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.01
- Shares outstanding
- 39,598,228
- Total 13F shares
- 18,509,095
- Share change
- -542,911
- Total reported value
- $12,216,040
- Price per share
- $0.66
- Number of holders
- 18
- Value change
- -$367,966
- Number of buys
- 5
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 75340L104?
CUSIP 75340L104 identifies RPID - RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75340L104:
Top shareholders of RPID - RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| KENNEDY LEWIS MANAGEMENT LP |
3/4/5
13F
|
10%+ Owner · Company |
12%
from 13F
|
2,904,490
|
$13,548,284 | — | 02 Jun 2022 | |
| Robert G. Spignesi Jr. |
13D/G
|
SPIGNESI ROBERT G JR |
6.3%
|
2,647,256
|
$9,133,033 | $0 | 28 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
13F
|
10%+ Owner · Company |
21%
from 13F
|
8,434,560
|
$8,345,154 | — | 19 Jul 2021 | |
| Jeffrey Lawrence Schwartz |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
8,477,510
mixed-class rows
|
$8,288,331 | — | 23 May 2024 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.3%
|
1,318,288
|
$1,278,739 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.6%
|
1,019,728
|
$989,136 | — | 31 Mar 2024 | |
| ABG-WTT Global Life Science Capital Partners GP Ltd |
13F
|
Company |
2.6%
|
1,038,296
|
$768,339 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
728,484
|
$706,629 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.6%
|
622,831
|
$604,146 | — | 31 Mar 2024 | |
| ADVENT INTERNATIONAL, L.P. |
13F
|
Company |
1.5%
|
577,777
|
$560,444 | — | 31 Mar 2024 | |
| Gurinder Grewal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
294,990
|
$291,863 | — | 19 Jul 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
161,153
|
$156,372 | — | 31 Mar 2024 | |
| Longitude Prime Partners, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
150,000
|
$148,410 | — | 19 Jul 2021 | |
| Jonathan Paris |
3/4/5
|
SVP, GENERAL COUNSEL |
—
mixed-class rows
|
325,398
mixed-class rows
|
$127,334 | — | 09 Mar 2023 | |
| Victoria Vezina |
3/4/5
|
CHIEF HUMAN RESOURCES OFFICER |
—
mixed-class rows
|
168,608
mixed-class rows
|
$110,468 | — | 11 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
66,187
|
$64,201 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
57,387
|
$56,000 | — | 31 Mar 2024 | |
| Richard A. Keys |
3/4/5
|
CHIEF COMMERCIAL OFFICER |
—
mixed-class rows
|
131,250
mixed-class rows
|
$43,286 | — | 11 Feb 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
26,074
|
$25,292 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
18,639
|
$18,080 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
15,650
|
$15,181 | — | 31 Mar 2024 | |
| David Hirsch |
3/4/5
|
Director |
—
mixed-class rows
|
42,950
mixed-class rows
|
$14,028 | — | 23 May 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
10,880
|
$11,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
10,108
|
$9,805 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,547
|
$5,381 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
246
|
$239 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
157
|
$152 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
83
|
$81 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
4
|
$4 | — | 31 Mar 2024 | |
| Alexander Schmitz |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 14 Jul 2021 |
Institutional Holders of RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID) as of Q2 2024
As of 30 Jun 2024,
RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,509,095 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, KENNEDY LEWIS MANAGEMENT LP, GLENVIEW CAPITAL MANAGEMENT, LLC, ABG-WTT Global Life Science Capital Partners GP Ltd, VANGUARD GROUP INC, BlackRock Inc., Advent International, L.P., JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
20
Q2 2024 holders
18
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.